LEGN
NASDAQ
US
Legend Biotech Corporation - American Depositary Shares
$19,14
▲ +$0,09
(+0,47%)
Vol. 1.2M
6
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$4.0B
ROE
-23,4%
Margine
-26,4%
D/E
40,57
Beta
0,08
52W
$21–$45
Consenso Wall Street
24 analisti · Apr 20267
Acquisto forte
14
Compra
3
Mantieni
0
Vendi
0
Vendita forte
87,5%
Rating Compra
Grafico dei Prezzi
Titoli simili
FOLD
Amicus Therapeutics Inc
$4.4B
VKTX
Viking Therapeutics Inc
$4.0B
ACAD
ACADIA Pharmaceuticals Inc
P/E 17,3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
DNLI
Denali Therapeutics Inc
$2.6B
DYN
Dyne Therapeutics Inc
$3.2B
TNGX
Tango Therapeutics Inc
$1.2B
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13,2
$2.9B
Utili
Tasso di battuta: 20,0%
Prossimo report
Mag 11, 2026
Stima EPS: $-0,03
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $-0,03 | — | — |
| Dic 2025 | $-0,11 | $-0,16 | $-0,05 |
| Set 2025 | $-0,09 | $-0,22 | $-0,13 |
| Giu 2025 | $-0,15 | $-0,68 | $-0,53 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $186.5M | $195.1M | $255.1M | $272.3M | $306.4M |
| Utile netto | — | $26.3M | -$100.9M | -$125.4M | -$39.7M | -$30.8M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -30.9% | -30.9% | -30.9% | -30.9% | -23.4% | -23.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -49.2% | -40.8% | -40.8% | -40.8% | -26.4% | -26.4% |
| Gross Margin | 61.6% | 62.5% | 62.5% | 62.5% | 60.5% | 60.5% |
| D/E Ratio | 37.46 | 37.46 | 37.46 | 37.46 | 40.57 | 40.57 |
| Current Ratio | 4.71 | 4.71 | 4.71 | 4.71 | 2.86 | 2.86 |
Rapporti chiave
ROA (TTM)
-14,4%
P/S (TTM)
4,42
P/B
5,7
EPS (TTM)
$-0,65
Crescita ricavi 3A
+108,9%
52W High
$45,30
52W Low
$21,19
$21,19
Intervallo 52 settimane
$45,30
Salute finanziaria
Flusso di cassa libero
-$24.6M
Debito netto
-$488.2M
Liquidità
$901.9M
Debito totale
$413.7M
Aggiornato al Dic 31, 2025
Як LEGN виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка LEGN vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
4,4
▼
66%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
5,7
▲
133%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість LEGN vs аналоги Biotechnology
ROE
-23,4%
▲
65%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
-26,4%
▲
91%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
60,6%
▼
23%
sotto
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
-14,4%
▲
69%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя LEGN vs аналоги Biotechnology
D/E ratio
40,6
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
2,9
▼
35%
sotto
peer
(4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,1
▼
92%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів LEGN
LEGN
Mediana peer
Industria
LEGN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
LEGN vs аналоги: ключові метрики
Principali azionisti
Top 5: 26,47%FMR, LLC
13,12%
$407.7M
Suvretta Capital Management…
3,57%
$111.0M
Westfield Capital Managemen…
3,33%
$103.6M
HHLR Advisors, LTD
3,24%
$100.5M
Deerfield Management Compan…
3,21%
$99.7M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora